A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targets. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1073/pnas.2110557119
PubMed Identifier: 35442775
Publication URI: http://europepmc.org/abstract/MED/35442775
Type: Journal Article/Review
Volume: 119
Parent Publication: Proceedings of the National Academy of Sciences of the United States of America
Issue: 17
ISSN: 0027-8424